Enhanced 4-valent Vaccine Against Seasonal Influenza

Norite gauti panašią informaciją kas rytą? Registruokitės 7 dienų NEMOKAMAI Mercell versijai!

The Norwegian Institute of Public Health (NIPH) would like to procure a enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enchanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD). The procurement will follow the rules for an open tender contest in accordance with the Public Procurements Act and regulations (LOA) parts 1 and 3, and will be made electronically in the contracting authority's electronic contest management tool, CTM (EU-Supply). According to the Public Procurement Regulations, section 20-2 (3), the tender deadline is 15 days. The aim is to enter into a contract for the delivery of 40 000 doses of enhanced 4-valent influenza vaccines. The tender documentation specifies the minimum requirements for the vaccine. A contract will be signed with one tenderer.